前瞻性心电图触发低剂量冠状动脉CT血管造影的长期预后性能
研究纳入434例疑似或已知冠心病并转诊行低剂量64层冠状动脉CT血管造影(CCTA)的患者,中位随访6.1±0.6年,评估主要不良心脏事件(MACE)。正常冠状动脉者MACE发生率为0%,非阻塞性病变为6%,阻塞性狭窄为30%,既往血运重建者为39%。低剂量CCTA长期预后性能优异,正常CCTA者无事件保证期超过6年。
要点
- 正常冠状动脉者随访6.1±0.6年MACE发生率为0%。
- 阻塞性狭窄和既往血运重建者MACE发生率分别为30%和39%。
- 冠状动脉钙化评分0分的患者中仍有4%发生MACE。
核心结论
- 前瞻性心电图触发低剂量CCTA长期预后性能优异,正常冠状动脉者无事件保证期超过6年,CCTA可按冠状动脉病变严重程度准确进行心脏风险分层。
研究设计与样本
- 纳入434例连续转诊行低剂量64层CCTA的疑似或已知冠心病患者,按正常、非阻塞性病变、阻塞性狭窄或既往血运重建分类,223例评估冠状动脉钙化评分(CACS),随访MACE(心源性死亡、心肌梗死和择期血运重建),行Kaplan-Meier分析和Cox回归。
关键影像表现/征象
- 基线时38%患者冠状动脉正常,21%为非阻塞性病变,32%为阻塞性狭窄,8%为既往血运重建。
- 平均有效辐射剂量为1.7±0.6 mSv。
- 中位随访6.1±0.6年,29例(7%)失访。
诊断标准与关键数值
- 正常冠状动脉者MACE发生率为0%,非阻塞性病变者为6%,阻塞性狭窄者为30%,既往血运重建者为39%。
- MACE发生率随CACS增加而升高(P < 0.001),但CACS=0的患者中4%发生MACE。
- 多变量Cox回归确定阻塞性狭窄、CCTA病变负荷和CACS为独立MACE预测因子(P ≤ 0.001)。
临床应用与阅片要点
- 正常CCTA提示无心脏事件保证期超过6年。
- CACS=0的患者仍可能发生心脏事件。
- CCTA可较ESC SCORE重新分类心脏风险。
局限性
- 29例(7%)失访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess long-term prognosis after low-dose 64-slice coronary computed tomography angiography (CCTA) using prospective electrocardiogram-triggering.
METHODS: We included 434 consecutive patients with suspected or known coronary artery disease referred for low-dose CCTA. Patients were classified as normal, with non-obstructive or obstructive lesions, or previously revascularized. Coronary artery calcium score (CACS) was assessed in 223 patients. Follow-up was obtained regarding major adverse cardiac events (MACE): cardiac death, myocardial infarction and elective revascularization. We performed Kaplan-Meier analysis and Cox regressions.
RESULTS: Mean effective radiation dose was 1.7 ± 0.6 mSv. At baseline, 38% of patients had normal arteries, 21% non-obstructive lesions, 32% obstructive stenosis and 8% were revascularized. Twenty-nine patients (7%) were lost to follow-up. After a median follow-up of 6.1 ± 0.6 years, MACE occurred in 0% of patients with normal arteries, 6% with non-obstructive lesions, 30% with obstructive stenosis and 39% of those revascularized. MACE occurrence increased with increasing CACS (P < 0.001), but 4% of patients with CACS = 0 experienced MACE. Multivariate Cox regression identified obstructive stenosis, lesion burden in CCTA and CACS as independent MACE predictors (P ≤ 0.001).
CONCLUSION: Low-dose CCTA with prospective electrocardiogram-triggering has an excellent long-term prognostic performance with a warranty period >6 years for patients with normal coronary arteries.
KEY POINTS: • Coronary CT angiography (CCTA) has an excellent long-term prognostic performance. • CCTA can accurately stratify cardiac risk according to coronary lesion severity. • A normal CCTA predicts freedom from cardiac events for >6 years. • Patients with a coronary calcium score of 0 may experience cardiac events. • CCTA allows for reclassification of cardiac risk compared with ESC SCORE.
引用
- Clerc OF, Kaufmann BP, Possner M, et al. Long-term prognostic performance of low-dose coronary computed tomography angiography with prospective electrocardiogram triggering. Eur Radiol. 2017. PMID: 28500370. doi:10.1007/s00330-017-4849-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。